Biological and clinical aspects of soluble transferrin receptor

被引:82
作者
Speeckaert, Marijn M. [1 ]
Speeckaert, Reinhart [1 ]
Delanghe, Joris R. [1 ]
机构
[1] Univ Ghent, Fac Med, Dept Clin Chem, Ghent, Belgium
关键词
Erythropoietin; iron metabolism; soluble transferrin receptor; standardization; transferrin; SICKLE-CELL-DISEASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; HUMAN SERUM TRANSFERRIN; HEREDITARY HEMOCHROMATOSIS PROTEIN; FUNCTIONAL IRON-DEFICIENCY; LINKED GLYCOSYLATION SITE; LOWER RESPIRATORY-TRACT; IGA NEPHROPATHY; SEMINAL PLASMA; MESSENGER-RNA;
D O I
10.3109/10408363.2010.550461
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Soluble transferrin receptor (sTfR), one of the main regulators of cellular iron homeostasis, is the truncated form of the tissue receptor that is encoded by the human TfR gene (chromosome 3). Serum sTfR levels are determined to detect iron deficiency (ID) in inflammatory states and in anemia of chronic disease (ACD) and to monitor the efficiency of erythropoietin (EPO) treatment. The levels of sTfR reflect the receptor density on cells (tissue iron status) and the number of cells with receptors (erythropoietic activity). Currently assays for the measurements of sTfR are standardized using different reference materials, give different results, and have different reference ranges. The recent development of a lyophilized preparation of recombinant soluble transferrin receptor (rsTfR) as a World Health Organization (WHO) reference reagent should help in the standardization of sTfR immunoassays. This article reviews the general characteristics of (s)TfR, the assays for sTfR, biological confounders in the assays, and the clinical applications for measuring sTfR.</.
引用
收藏
页码:213 / 228
页数:16
相关论文
共 173 条
[1]   PLASMA FERRITIN CONCENTRATIONS IN ANEMIC CHILDREN - RELATIVE IMPORTANCE OF MALARIA, RIBOFLAVIN DEFICIENCY, AND OTHER INFECTIONS [J].
ADELEKAN, DA ;
THURNHAM, DI .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 51 (03) :453-456
[2]   Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure [J].
Ahluwalia, N ;
Skikne, BS ;
Savin, V ;
Chonko, A .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (04) :532-541
[3]  
AHN JH, 1993, BLOOD, V81, P2442
[4]   Evaluation of kits for measurement of the soluble transferrin receptor [J].
Åkesson, A ;
Bjellerup, P ;
Vahter, M .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1999, 59 (02) :77-81
[5]  
Allen J, 1998, CLIN CHEM, V44, P35
[6]  
[Anonymous], 2001, INCIDENCE SELECTED C, P1
[7]  
Banfi G, 2009, J SPORT MED PHYS FIT, V49, P308
[8]   A world apart Inaccuracies of laboratory methodologies in antidoping testing [J].
Banfi, Giuseppe ;
Lombardi, Giovanni ;
Colombini, Alessandra ;
Lippi, Giuseppe .
CLINICA CHIMICA ACTA, 2010, 411 (15-16) :1003-1008
[9]  
BARTHELEMY C, 1988, J REPROD FERTIL, V82, P113
[10]   SERUM TRANSFERRIN RECEPTOR IN HEREDITARY HEMOCHROMATOSIS AND AFRICAN SIDEROSIS [J].
BAYNES, RD ;
COOK, JD ;
BOTHWELL, TH ;
FRIEDMAN, BM ;
MEYER, TE .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 45 (04) :288-292